Retroscreen Virology Group PLC Change of Name to hVIVO plc (9406J)
13 Avril 2015 - 8:00AM
UK Regulatory
TIDMRVG
RNS Number : 9406J
Retroscreen Virology Group PLC
13 April 2015
For immediate release 07:00: 13 April 2015
RETROSCREEN VIROLOGY GROUP PLC
("Retroscreen" or the "Company")
CHANGE OF NAME TO HVIVO PLC
As detailed in its H1'14 Half Year Financial Report announced on
25 September 2014, Retroscreen will be changing its name to hVIVO
plc which is currently the Company's proprietary name for its
technology platform. The Company's change of name is being
registered at Companies House and is expected to become effective
on 16 April 2015.
Trading in the Company's shares on AIM under the new name of
hVIVO plc (AIM: HVO) is expected to take effect from 8.00am on 16
April 2015.
A further announcement will be made as soon as the name change
has taken effect.
For further information please contact:
Retroscreen Virology Group plc +44 207 756 1300
Kym Denny (CEO)
Graham Yeatman (FD)
Media Enquiries +44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public
Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
Retroscreen Virology Group plc ("Retroscreen") is a rapidly
growing life sciences company pioneering human models of disease to
accelerate drug development and promote disease understanding.
Based in the UK, Retroscreen has conducted over 40 clinical
studies, involving more than 1900 volunteers for a range of leading
industry, governmental and academic clients.
This information is provided by RNS
The company news service from the London Stock Exchange
END
CANKMGMDMMFGKZM
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024